Pre-Clinical Trial Application (CTA) Consultation Meeting
The pre-CTA consultation meeting provides an opportunity for the sponsor to present relevant data, discuss concerns and resolve issues regarding drug development. It also gives Health Canada an opportunity to provide guidance on the acceptability of the proposed trial(s).
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Pre-Clinical Trial Application (CTA) Consultation MeetingHTMLEnglish publication HTML
Pre-Clinical Trial Application (CTA) Consultation MeetingHTMLFrench publication HTML